Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Consider this

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Oct 26, 2023 8:23pm

97 Views

Post# 35703299

RE:RE:RE:RE:RE:RE:Consider this

You want a fix... get Luc back and pay him well or get someone like Bellinni. The board with De Granpre and Pommier was respected but no respect for anyone there now. Management is out of nightmare truly. They just confirmed that the company is worth 25 cents by agreeing to sell 50% of it for that price. It's only worth as much as your last deal. That's it now thanks to your stubborn stupidity.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland